Simon Paul Poidevin, born on October 31, 1958, is a retired Australian rugby union player renowned for his illustrious career. Notably, he played a pivotal role in the Wallabies' historic achievements, including the 1980 Bledisloe Cup victory against New Zealand, the 1984 "grand slam" tour of Britain and Ireland, and the 1991 Rugby World Cup triumph. Poidevin, a distinguished captain, stands among a select group of four Australian rugby icons to have secured rugby union's Grand Slam, claimed a series win in New Zealand, and earned a Rugby World Cup title.
Copyright 2023 – Finance News Network
30 Mar 2023 - Veris Limited (ASX:VRS) Managing Director and CEO Dr Michael Shirley provides an introduction to the company, discussing its services, the competitive landscape, revenue breakdown, growth opportunities and strategy.
06 Mar 2023 - Keith Cullen, Founder and Managing Director of WT Financial Group Limited (ASX:WTL) discusses the company's half-year results, why the rising cost of financial advice is good for the profession, the company's direct-to-consumer channel, the Quality of Advice Review, the prospects for further acquisitions, and dividends.
22 Nov 2021 - Arovella Therapeutics Limited (ASX:ALA) CEO & Managing Director Dr Michael Baker provides an update on the company's invariant Natural Killer T (iNKT) cell platform and its oral spray delivery technology to treat cancer and conditions that affect the central nervous system.
04 Sep 2023 - Glen Diemar, Managing Director of Australian Gold and Copper Limited (ASX:AGC), provides an update on the company, discussing drill targets, plans and outlook.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
14 Dec 2022 - RareX Limited (ASX:REE) Managing Director Jeremy Robinson discusses progress at the Cummins Range rare earths project and a potential resource upgrade.
14 Aug 2019 - ALE Property Group Limited (ASX:LEP) Managing Director, Andrew Wilkinson discusses the company’s FY19 results, valuations and rent reviews
02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.
